Summary of Purpose
The Registry of Acute Stroke Under Novel Oral Anticoagulants-Prime (RASUNOA-Prime), an investigator-initiated study, is a German multicenter, prospective, observational registry. It is performed at about 50 certified stroke-units and supported by an unrestricted grant from different pharmaceutical companies to the Heidelberg University Hospital. RASUNOA-Prime is designed to assess the emergency management of...Read More →
The following dates are available for this trial. Trial information last updated on 1 May 2017.
|1 Jun 2015||23 Aug 2015||1 Dec 2019||1 Dec 2019||1 May 2017||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
Conditions See All
Sponsors See All
- Observation: Cohort
- Perspective: Prospective
- Sampling: Probability Sample
- Timolaos Rizos, MD
- Roland Veltkamp, Prof. Dr. med.